This Solicitation opportunity from Department Of Defense was posted on August 4, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
OCLACITINIB MALEATE TA
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Oclacitinib Maleate Tablets, 16mg, marketed as Apoquel, are being procured by the Defense Logistics Agency for the control of pruritus associated with allergic dermatitis and atopic dermatitis in dogs. The contract specifies a total quantity of two bottles, each containing 100 tablets, with a total contract value of $385.50. Delivery is required within 89 days after award, with FOB destination terms placing full responsibility for transportation and risk on the contractor until the goods reach the designated delivery point: USAMMC E DISTR AND TRANS DIVISION, LUDWIGSHAFENERSTRASSE 31 BLDG 2369, KAISERSLAUTERN 67657, DE. Inspection and acceptance occur at the destination, and the item is subject to a strict 36-month non-extendable shelf life with storage required at controlled room temperature between 20°C and 25°C, allowing excursions between 15°C and 40°C. Packaging must comply with MIL-STD-2073-1E using commercial standards, with unit containers sealed to protect contents and exterior shipping containers optimized for safe, low-cost delivery by common carrier. All labeling must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items; this includes mandatory marking of the NSN 6509017194946 and adherence to special marking code ZZ where applicable. The tablets are regulated by the FDA and classified as a Type I (Code Q) item with no shelf-life extension permitted. The procurement is governed by numerous Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses covering equal opportunity, trafficking in persons, hazardous material identification, sustainable products, employment eligibility verification, and cybersecurity requirements including NIST SP 800-171. Contractors must use Wide Area WorkFlow for invoicing and comply with the U.S.-flag vessel requirement for ocean transport, with waiver requests needing to be submitted 45 days in advance. Proposals must be submitted electronically via the DLA Internet Bid Board System by the August 11, 2026 deadline. The solicitation includes no option quantities or ranges, and award is expected to be based on price and technical acceptability, without a specified evaluation method. All materials must meet the technical and quality requirements listed in the DLA Master List
General Info
Place of Performance
ATTN CL VIII MED REQ PROCES ACT, APO, AE, 09227-0000, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
OCLACITINIB MALEATE TABLETS
.
"APOQUEL", 16MG TABLETS; CONTROL OF PRURITUS ASSOCIATED WITH ALLERGIC
DERMATITIS AND CONTROL OF ATOPIC DERMATITIS IN DOGS
.
UNIT OF ISSUE: BOTTLE (BT) OF 100EA
.
STORE AT CONTROLLED ROOM TEMPERATURE BETWEEN
20DEG 25DEG C (68DEG 77DEG) WITH EXCURSIONS BETWEEN
15DEG 40DEG C (59DEG 104DEG F).
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
. .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
COVETRUS NORTH AMERICA, LLC 4PG41 P/N 069194 ZOETIS INC. 0M1P3 P/N 10009492 ZOETIS INC. 0M1P3 P/N NDC54771-8723-02
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4474
SECTION B
PR: 7017744598 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017744598 0001 BT 2.000
NSN/MATERIAL:6509017194946
DELIVERY (IN DAYS):0089
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
CMR 469
SPE2DP-26-T-4474
SECTION B
PR: 7017744598 PRLI: 0001 CONT’D
ATTN CL VIII MED REQ PROCES ACT
APO AE 09227-0000
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4FV1
W0CC USA MED MAT CTR EUR
USAMMC E DISTR AND TRANS DIVISION
LUDWIGSHAFENERSTRASSE 31 BLDG 2369
KAISERSLAUTERN 67657
DE
Need Ship Date:00/00/0000 Original Required Delivery Date:08/04/2026
SPE2DP-26-T-4474 NSN/Part Number: 6509-01-719-4946 Quantity: 2 BT Purchase Request: 7017744598QTY: 2 Delivery: 89 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
